{
      "StudyFieldsResponse": {
            "APIVrs": "1.01.05",
            "DataVrs": "2022:10:06 23:25:58.836",
            "Expression": "NCT02652130",
            "NStudiesAvail": 430108,
            "NStudiesFound": 1,
            "MinRank": 1,
            "MaxRank": 1000,
            "NStudiesReturned": 1,
            "FieldList": [
                  "OutcomeClassDenomCountGroupId",
                  "OutcomeClassDenomCountValue",
                  "OutcomeClassDenomUnits",
                  "OutcomeClassTitle",
                  "OutcomeDenomCountGroupId",
                  "OutcomeDenomCountValue",
                  "OutcomeDenomUnits",
                  "OutcomeGroupDescription",
                  "OutcomeGroupId",
                  "OutcomeGroupTitle",
                  "OutcomeMeasureAnticipatedPostingDate",
                  "OutcomeMeasureCalculatePct",
                  "OutcomeMeasureDenomUnitsSelected",
                  "OutcomeMeasureDescription",
                  "OutcomeMeasureDispersionType",
                  "NCTId"
            ],
            "StudyFields": [
                  {
                        "Rank": 1,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [
                              "OG000",
                              "OG000"
                        ],
                        "OutcomeDenomCountValue": [
                              "54",
                              "38"
                        ],
                        "OutcomeDenomUnits": [
                              "Participants",
                              "Participants"
                        ],
                        "OutcomeGroupDescription": [
                              "All participants who were enrolled and had received at least 1 dose of remestemcel-L in Study MSB-GVHD001.",
                              "All participants who were enrolled and had received at least 1 dose of remestemcel-L in Study MSB-GVHD001."
                        ],
                        "OutcomeGroupId": [
                              "OG000",
                              "OG000"
                        ],
                        "OutcomeGroupTitle": [
                              "Remestemcel-L",
                              "Remestemcel-L"
                        ],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [
                              "The overall survival rate is defined as the percentage of participants alive at the given time point. OS is defined as the time to death from the start of drug therapy.",
                              "The overall survival rate is defined as the percentage of participants alive at the given time point. OS is defined as the time to death from the start of drug therapy."
                        ],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT02652130"
                        ]
                  }
            ]
      }
}